Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats

Neurochemical Research

Volumn 39, Issue 5, 2014, Pages 825-832

  Ago, Yukio ^a   Umehara, Masato ^a   Higashino, Kosuke ^a   Hasebe, Shigeru ^a   Fujita, Kazumi ^a   Takuma, Kazuhiro ^a   Matsuda, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Atomoxetine; Dopamine; Norepinephrine; Prefrontal cortex; Spontaneously hypertensive rat (SHR)

Indexed keywords

ATOMOXETINE; DOPAMINE; MONOAMINE; NORADRENALIN; POTASSIUM ION; SEROTONIN; POTASSIUM; PROPYLAMINE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN LEVEL; CONTROLLED STUDY; DOPAMINE RELEASE; EXTRACELLULAR SPACE; GENETIC SIMILARITY; MALE; MONOAMINE RELEASE; NONHUMAN; NORADRENALIN RELEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTEMIC THERAPY; WISTAR KYOTO RAT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

RATTUS;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODELS, ANIMAL; DOPAMINE; MALE; NOREPINEPHRINE; POTASSIUM; PREFRONTAL CORTEX; PROPYLAMINES; RATS, INBRED SHR; RATS, INBRED WKY; SEROTONIN;

EID: 84905374350     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1275-5     Document Type: Article

References (33)

1. Pliszka SR (2005) The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 57(11):1385-1390
2. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1239-1247 (Pubitemid 40798541)
3. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J (1995) Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Res 676(2):343-351
4. 3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94(1):163-171
5. Russell V, Allie S, Wiggins T (2000) Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Res 117(1-2):69-74
6. Russell VA (2002) Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Res 130(1-2):191-196
7. Carboni E, Silvagni A, Valentini V, Di Chiara G (2003) Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdialysis study. Neurosci Biobehav Rev 27(7):653-659 (Pubitemid 37414913)
8. Heal DJ, Smith SL, Kulkarni RS, Rowley HL (2008) New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol Biochem Behav 90(2):184-197. doi:10.1016/j.pbb.2008.03.016
9. Gibson AP, Bettinger TL, Patel NC, Crismon ML (2006) Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann Pharmacother 40(6):1134-1142 (Pubitemid 43886972)
10. Umehara M, Ago Y, Fujita K, Hiramatsu N, Takuma K, Matsuda T (2013) Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats. Eur J Pharmacol 702(1-3):250-257. doi:10.1016/j.ejphar.2013.01.033
11. Umehara M, Ago Y, Kawanai T, Fujita K, Hiramatsu N, Takuma K, Matsuda T (2013) Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation. Behav Pharmacol 24(4):328-331. doi:10.1097/FBP.0b013e3283633648
12. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington
13. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
14. Ago Y, Araki R, Tanaka T, Sasaga A, Nishiyama S, Takuma K, Matsuda T (2013) Role of social encounter-induced activation of prefrontal serotonergic systems in the abnormal behaviors of isolation-reared mice. Neuropsychopharmacology 38(8):1535-1547. doi:10.1038/npp.2013.52
15. Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T (2010) Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of norepinephrine, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 114(1):259-270. doi:10.1111/j.1471- 4159.2010.06750.x
16. 1 receptor activation. Psychopharmacology 217(3):377-386. doi:10.1007/s00213-011-2293-5
17. Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24(1):31-39
18. Arnsten AF, Rubia K (2012) Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 51(4):356-367. doi:10.1016/j.jaac.2012.01.008
19. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 220(3):1208-1515
20. Li Q, Lu G, Antonio GE, Mak YT, Rudd JA, Fan M, Yew DT (2007) The usefulness of the spontaneously hypertensive rat to model attention-deficit/ hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem Int 50(6):848-857
21. Sagvolden T, Johansen EB, Wøien G, Walaas SI, Storm-Mathisen J, Bergersen LH, Hvalby O, Jensen V, Aase H, Russell VA, Killeen PR, Dasbanerjee T, Middleton FA, Faraone SV (2009) The spontaneously hypertensive rat model of ADHD - the importance of selecting the appropriate reference strain. Neuropharmacology 57(7-8):619-626. doi:10.1016/j.neuropharm.2009.08.004
22. Mc Fie S, Sterley TL, Howells FM, Russell VA (2012) Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/ hyperactivity disorder. Brain Res 1467:91-103. doi:10.1016/j.brainres.2012.05. 047
23. Miller EM, Pomerleau F, Huettl P, Russell VA, Gerhardt GA, Glaser PE (2012) The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens. Neuropharmacology 63(8):1327-1334. doi:10.1016/j. neuropharm.2012.08.020
24. 3H]-tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites. Neurosci Lett 157(2):203-206
25. 3H]GBR 12935 as markers of dopamine innervation density in brain. Synapse 25(2):163-175
26. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18(7):2697-2708 (Pubitemid 28141815)
27. Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the norepinephrine carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55(3):1067-1070
28. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997) Contribution of blockade of the norepinephrine carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9(10):2077-2085 (Pubitemid 27485240)
29. Yamamoto BK, Novotney S (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71(1):274-280 (Pubitemid 28292559)
30. Grenhoff J, Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233(1):79-84 (Pubitemid 23091746)
31. Shi WX, Pun CL, Zhang XX, Jones MD, Bunney BS (2000) Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and non dopamine receptors. J Neurosci 20(9):3504-3511 (Pubitemid 30263765)
32. Linnèr L, Endersz H, Öhman D, Bengtsson F, Schalling M, Svensson T (2001) Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther 297(2):540-546 (Pubitemid 32377983)
33. Easton N, Steward C, Marshall F, Fone K, Marsden C (2007) Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and norepinephrine in vitro in the rat brain. Neuropharmacology 52(2):405-414 (Pubitemid 46137974)